SAMN43213414
External Id
Wayne State University
INSDC center name
2024-08-15T00:00:00Z
INSDC first public
2024-08-20T19:13:34.100Z
INSDC last update
live
INSDC status
Pathogen.cl
NCBI submission model
Pathogen.cl.1.0
NCBI submission package
Baltz > Bayer > Rybak
Provenance
Cubist Pharmaceuticals
collected_by
unknown
collection_date
ST5-MRSA-IVa CC5
genotype
unknown
geo_loc_name
Homo sapiens
host
Clinical bloodstream isolate CUBIST-33 is part of the Cubist Pharmaceuticals Isolate Collection. CUBIST-33 is the daptomycin-resistant isolate of the CUBIST-32/CUBIST-33 sequential isolate paired strains obtained from a patient with endovascular staphylococcal infection following daptomycin treatment failure. It is multilocus sequence type 5, clonal complex 5, SCCmec-IVa (+), spa type t002 / T1-J1-M1-B1-M1-D1-M1-G1-M1-K1. Compared to CUBIST-32, CUBIST-33 has sequence variations in walK (L494V), and in mprF (S337L). It was previously described in a 2015 report as strain "C33".
host_description
staphylococcal endovascular infection
host_disease
blood
isolation_source
unknown
lat_lon
Staphylococcus aureus
http://purl.obolibrary.org/obo/NCBITaxon_1280
organism
CUBIST-33
strain
CUBIST-33
title